PERSPECTA

News from every angle

← Back to headlines

Johnson & Johnson Acquires Firefly Bio for $1 Billion

Johnson & Johnson has announced its acquisition of Firefly Bio, a company specializing in cancer drug technology development, for $1 billion in cash. This strategic move aims to bolster J&J's oncology pipeline.

8 Jun, 13:33 — 8 Jun, 13:33
PostShare

Sources

Showing 1 of 3 sources
YahooMostly Factual62d ago

Johnson & Johnson acquires Firefly Bio for $1 billion

Read full article →

Coverage Timeline

First report: seeking-alpha · 8 Jun, 12:42Full coverage: 3 · 51mWindow: 51m
Left-leaningCenterRight-leaning
seeking-alpha8 Jun, 12:42First to report

Johnson & Johnson to buy Firefly Bio for $1B in cash

naftemporiki8 Jun, 12:48

Η Johnson & Johnson εξαγοράζει την Firefly Bio, εταιρεία ανάπτυξης τεχνολογίας φαρμάκων για τον καρκίνο, έναντι 1 δισεκ. δολαρίων

Yahoo8 Jun, 13:33Latest update

Johnson & Johnson acquires Firefly Bio for $1 billion

Related Stories

Europe Begins Lithium Mining in Finland

13m ago

Single Mother Executive Details Monthly Finances

15m ago

Bloomberg Weekend Roundup of Missed Headlines

16m ago

Romania Sinks Barges in Danube to Support Cernavodă Nuclear Plant

16m ago